Dr. Lubin leads the Diagnostic Excellence Initiative (DEI) out of the Division of Laboratory Systems, Centers for Disease Control and Capacity. The DEI works and collaborates with the private and public health sectors to leverage clinical laboratory expertise, capabilities, and data to advance diagnostic excellence and promote health equity across healthcare delivery settings and medical disciplines. Dr. Lubin has been at CDC for greater than 20 years, has held various leadership roles, and maintains board certification in clinical molecular genetics. He has made substantive contributions to public health, laboratory medicine, health systems translational studies, and standards/policy development. Dr. Lubin has participated as member, presenter, and chair to federal and professional groups and advisory committees.